Author: Justin Chakma

Justin Chakma is a life sciences venture capital investor with Thomas, McNerney & Partners in La Jolla, CA. He has published over 20 articles in peer-reviewed journals on healthcare policy and innovation, including the New England Journal of Medicine.

U.S. Biomedical Research at a Precipice

[Editor’s Note: this post was co-authored by Justin Chakma, Dr. Reshma Jagsi, and Stephen M. Sammut.] Since 1950, U.S. government funding has supported research underlying 84 percent of Nobel Prizes awarded in Medicine & Physiology. These scientific breakthroughs have resulted in new medicines and created significant economic value. For example, the discovery of gene silencing, … Continue reading “U.S. Biomedical Research at a Precipice”